Načítá se...
Therapeutic advances in idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is characterised by progressive accumulation of scar tissue in the lung and is associated with a median life expectancy of 2–4 years. Until recently, treatment options were limited, focusing on ineffective anti-inflammatory therapy, palliation, transplant or trial...
Uloženo v:
| Vydáno v: | Clin Med (Lond) |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Royal College of Physicians
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4954329/ https://ncbi.nlm.nih.gov/pubmed/26833513 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7861/clinmedicine.16-1-42 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|